Development of personalized cancer immunotherapy
Location: United States
Total raised: $10M
Investors 3
Date | Name | Website |
- | Korea Inve... | partners.k... |
06.04.2022 | Flerie Inv... | flerie.com |
- | 3B Future ... | 3bfuturehe... |
Funding Rounds 2
Date | Series | Amount | Investors |
05.10.2023 | - | $5M | - |
12.04.2023 | - | $5M | - |
Mentions in press and media 11
Date | Title | Description | Source |
05.10.2023 | Geneos Therapeutics: Clinical-Stage Biotherapeutics Company ... | Geneos Therapeutics – a clinical-stage biotherapeutics company focused on developing personalized th... | pulse2.com... |
28.09.2023 | Geneos Therapeutics Closes $5M Series A3 Financing | Geneos Therapeutics, a Plymouth Meeting, PA-based clinical stage biotherapeutics company, raised $5M... | finsmes.co... |
12.04.2023 | Geneos Therapeutics Raises $5M in Series A3 Financing | Geneos Therapeutics, a Plymouth Meeting, PA-based clinical stage biotherapeutics company, raised $5M... | finsmes.co... |
25.03.2022 | Geneos Therapeutics Raises $17M in Series A2 Funding | Geneos Therapeutics, a Plymouth Meeting, PA-based clinical stage biotherapeutics company, raised $17... | finsmes.co... |
16.03.2021 | VGXI and Geneos Therapeutics Expand Partnership for Personal... | The renewed agreement is a testament to the experience and capabilities of the VGXI team in meeting ... | prweb.com/... |
08.03.2021 | Geneos Therapeutics Raises $12M in Series A1 Financing | Geneos Therapeutics, a Plymouth Meeting, Pa.-based clinical stage company focused on the development... | finsmes.co... |
22.02.2019 | Term Sheet — Friday, February 22 | THREE THINGS Happy Friday, Term Sheet readers. Paid Content Securing the enterprise without bounda... | fortune.co... |
21.02.2019 | Top startup news for today, Thursday, February 21, 2019 | Good morning! Here are some of the top technology startup news stories for today, Thursday, February... | techstartu... |
21.02.2019 | Geneos Therapeutics Receives $10.5M Series A | PLYMOUTH MEETING, PA, Geneos Therapeutics announced today that it has closed its Series A round ra... | vcnewsdail... |
21.02.2019 | Geneos Therapeutics Secures $10.5M in Series A Financing | Geneos Therapeutics, a Plymouth Meeting, Pa.-based developer of neoantigen-targeting cancer immunoth... | finsmes.co... |
Show more